Tissue Repair (ASX:TRP) EBITDA Margin %: -1,070.59% (As of Dec. 2025)


ASX:TRP Tissue Repair Ltd ASX:TRP
29 GF Score
Price A$0.11
View Full Analysis

What is Tissue Repair EBITDA Margin %?

Tissue Repair ASX:TRP 29 EBITDA Margin % is -1,070.59% as of Dec. 2025. GuruFocus rates ASX:TRP with a GF Score™ of 29/100. Among 944 Biotechnology companies, Tissue Repair ranks worse than 81.14% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tissue Repair's EBITDA for the six months ended in Dec. 2025 was A$-3.28 Mil. Tissue Repair's Revenue for the six months ended in Dec. 2025 was A$0.31 Mil. Therefore, Tissue Repair's EBITDA margin for the quarter that ended in Dec. 2025 was -1,070.59%.

Tissue Repair  (ASX:TRP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Tissue Repair EBITDA Margin % Related Terms

Tissue Repair EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Tissue Repair's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Repair EBITDA Margin % Chart

Tissue Repair Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA Margin %
0.00 0.00 -191,266.67 -4,286.18 -1,638.53

Tissue Repair Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,293.22 -4,236.17 -1,841.92 -1,460.00 -1,070.59

ASX:TRP vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Tissue Repair's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Repair EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Repair's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tissue Repair's EBITDA Margin % falls into.


ASX:TRP
29GF Score
Tissue Repair Ltd ASX:TRP
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Repair EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tissue Repair's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-6.931/0.423
=-1,638.53 %

Tissue Repair's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.276/0.306
=-1,070.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -1,070.59% mean?
Tissue Repair (ASX:TRP) has a EBITDA Margin % of -1,070.59% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tissue Repair and its competitors. According to the industry distribution chart, Tissue Repair ranks #766 out of 944 companies in the Biotechnology industry, placing it in the top 81.1%.
Is Tissue Repair's EBITDA Margin % too high?
Tissue Repair's current EBITDA Margin % is -1,070.59%. Based on the distribution chart, Tissue Repair ranks #766 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tissue Repair has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Repair's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tissue Repair ranks #766 out of 944 companies for EBITDA Margin %. This places Tissue Repair in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tissue Repair and its competitors. Tissue Repair's current EBITDA Margin % is -1,070.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Repair stock overvalued right now?
Tissue Repair (ASX:TRP) has a current EBITDA Margin % of -1,070.59%. The current EBITDA Margin % is -1,070.59%. Tissue Repair's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tissue Repair (ASX:TRP), the current EBITDA Margin % is -1,070.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Repair Business Description

Address 821 Pacific Highway, Tower A, Level 9, The Zenith, Chatswood, NSW, AUS, 2067
Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.
29GF Score

Get the complete analysis for ASX:TRP

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price